Skip to content
  • Home
  • About Us
  • Longevity Platform
  • Bio101
    • BIO101 in Sarcopenia
    • BIO101 in Obesity
  • Other Projects
  • Resources
    • Posters & Publications
    • Scientific Press Releases
  • Recruitment
  • Investors
    • Stock Information
    • Corporate Presentation
    • Letter to shareholders
    • Press Releases
    • General Meetings
    • AMF Regulated Information
    • SEC Filings
    • Convertible bonds
    • Contact for Investors
  • Contact
  • EN
  • EN

JULY 19, 2021

Press Releases, StrategyBy adminJuly 20, 2021

Judgment rendered on July 16, 2021 in the proceedings between Biophytis and Negma Group Ltd by the Execution Judge from the Paris Court of Justice

X
Addresses
Addresses

BIOPHYTIS France
Silver Innov’
54 rue Moliรจre
94200 Ivry-Sur-Seine
FRANCE

Addresses

BIOPHYTIS USA
c/o NGIN
210 Broadway, Suite #201
Cambridge, MA 02139
USA

Addresses

BIOPHYTIS Brazil
CIETEC
Av. Prof. Lineu Prestes
2242 Cidade Universitรกria USP
05508-000 Sรฃo Paulo
BRASIL

Contact
contact@biophytis.com +33 1 76 28 40 83
Investors

investors@biophytis.com

ยฉ Biophytis 2025.

All Rights Reserved.

Legal information
Webdesign by Ex Calibra
Go to Top
  • Home
  • About Us
  • Longevity Platform
  • Bio101
    • BIO101 in Sarcopenia
    • BIO101 in Obesity
  • Other Projects
  • Resources
    • Posters & Publications
    • Scientific Press Releases
  • Recruitment
  • Investors
    • Stock Information
    • Corporate Presentation
    • Letter to shareholders
    • Press Releases
    • General Meetings
    • AMF Regulated Information
    • SEC Filings
    • Convertible bonds
    • Contact for Investors
  • Contact
  • Home
  • About Us
  • Longevity Platform
  • Bio101
    • BIO101 in Sarcopenia
    • BIO101 in Obesity
  • Other Projects
  • Resources
    • Posters & Publications
    • Scientific Press Releases
  • Recruitment
  • Investors
    • Stock Information
    • Corporate Presentation
    • Letter to shareholders
    • Press Releases
    • General Meetings
    • AMF Regulated Information
    • SEC Filings
    • Convertible bonds
    • Contact for Investors
  • Contact